Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.

Mid Cap Biotechnology Analyst Joseph and European Pharmaceuticals Analyst Gordon, along with Dr. Hogarth, Prof of Medicine in Pulmonary & Critical ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

The "Laboratory Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Global Laboratory Supplies ...

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

Heritable Genetic Modification in Food Animals, a new congressionally mandated report from the National Academies of Sciences ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

ORIC Pharmaceuticals is advancing ORIC-114 for 1st-line EGFR/HER2 exon 20 NSCLC, with comprehensive data expected in the 2nd ...

Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a ...

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.

On the buying side, ARK’s ARKG ETF acquired 2161 shares of biopharmaceutical giant Amgen Inc (NASDAQ: AMGN ), with a total investment of around $599,223. This purchase signals a growing interest in ...